Tumour-induced Osteomalacia Secondary to a Sarcoma
Open Access
- 1 January 2016
- journal article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 12 (2), 104-106
- https://doi.org/10.17925/EE.2016.12.02.104
Abstract
Tumour-induced osteomalacia (TIO), is a rare paraneoplasatic syndrome found in >95% of benign tumours that secrete fibroblast growth factor 23 - a phosphaturic circulating hormone. A rare case of a TIO secondary to a sarcoma, in a 21-year old man with history of bone fractures and distinctive physical and biochemical characteristics is presented and discussed.Keywords
This publication has 15 references indexed in Scilit:
- Oncogenic Osteomalacia due to FGF23-Expressing Colon AdenocarcinomaJournal of Clinical Endocrinology & Metabolism, 2013
- Tumor-induced osteomalaciaEndocrine-Related Cancer, 2011
- Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic EntityThe American Journal of Surgical Pathology, 2004
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences of the United States of America, 2001
- Oncogenic Osteomalacia as a Harbinger of Recurrent OsteosarcomaSarcoma, 1999
- Osteomalacia secondary to osteosarcoma. A case report.The Journal of Bone & Joint Surgery, 1989
- Hypophosphataemic osteomalacia associated with a malignant tumour of the tibia: report of a case.Journal of Clinical Pathology, 1977
- Hypophosphataemic Osteomalacia with Complete RecoveryBMJ, 1964
- [Rickets following bone tumor].1959
- Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years.1947